TMS - A PROVEN THERAPY FOR OBSESSIVE COMPULSIVE DISORDER
Leading Connecticut & Massachusetts Provider
Achieve TMS East Among the First to Offer FDA-Approved dTMS Treatment for OCD
Achieve TMS East, a leading provider of deep Transcranial Magnetic Stimulation (TMS) for the treatment of major depressive disorder (MDD), is offering treatment for Obsessive Compulsive Disorder (OCD) at several of its select centers in Massachusetts including Northampton, Leominster, and Westborough. Our technicians use Brainsway’s deep TMS technology, offering our patients the most advanced technology for the treatment of OCD and Major Depression. It was in August 2018 that Brainsway’s OCD treatment protocol was approved by the FDA.
How dTMS Treatment for OCD Works
Patient's Treatment Stories
Treating OCD with Deep TMS
Achieve Offices Offering OCD Treatment
Achieve TMS East is pleased to offer TMS Therapy for the treatment of OCD at our Leominster, Northampton, and Westborough MA offices!
Insurance Coverage for TMS
Insurance accepted for treating Depression, specifically TMS therapy, has more than doubled in the last few years, a sign that insurance companies must see cost savings in a treatment method for major depressive disorder (MDD) that works more efficiently than the traditional regimen alone. Patients who continually suffer from the debilitating effects of medication-resistant depression may acquire other health conditions as a result, such as a substance abuse disorder or unhealthy weight gain, to name a few. The fact that more and more insurance companies are providing coverage for TMS indicates a cost benefit to the insurer, thus the broadening of benefits.
The following are some of the insurance plans currently working with Achieve TMS East: Aetna, BCBS, BMC, Cigna, Commonwealth Care Alliance, Fallon Health, GIC, Harvard Pilgrim, Husky, Masshealth PCC Plan, Medicare, Neighborhood Health Plan, One Care, Tricare, Tufts Health Plan, and United Health Care. If you don’t see your plan listed, please call and ask us about yours today.